Pesquisar um ensaio clínico
Outras opções de pesquisa
9 Resultado(s)
Ensaio em fase de recrutamento = 
; Ensaio a decorrer = 
; Financiado por um membro do IRDiRC = 
; Membro de uma ERN = 
Ensaio (s) clínico (s) nacional (is)
ESPANHA
Aragón
ZARAGOZA
A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-pubertal children with growth hormone deficiency - ES
Hospital Universitario Miguel Servet
Servicio de Pediatría
ESPANHA
Asturias
OVIEDO
A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-pubertal children with growth hormone deficiency - ES
Hospital Universitario Central de Asturias
Servicio de Pediatría
ESPANHA
Cataluña
BADALONA
A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-pubertal children with growth hormone deficiency - ES
Hospital Germans Trias I Pujol
Servicio de Pediatría
ESPANHA
Cataluña
ESPLUGUES DE LLOBREGAT
A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-pubertal children with growth hormone deficiency - ES
Hospital Sant Joan de Déu Barcelona
Servicio de Endocrinología
ESPANHA
Cataluña
GIRONA
A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-pubertal children with growth hormone deficiency - ES
Hospital Universitari de Girona Dr. Josep Trueta
Servicio de Pediatría
ESPANHA
Cataluña
SABADELL
A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-pubertal children with growth hormone deficiency - ES
Corporación Sanitaria Parc Taulí. Hospital de Sabadell
Unidad de Endocrinología Pediátrica
ESPANHA
Galicia
SANTIAGO DE COMPOSTELA
A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-pubertal children with growth hormone deficiency - ES
Hospital Clínico Universitario de Santiago
Servicio de Pediatría
ESPANHA
Navarra
PAMPLONA
A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-pubertal children with growth hormone deficiency - ES
Complejo Hospitalario de Navarra
Servicio de Pediatría
ESPANHA
País Vasco
VITORIA-GASTEIZ